- Home
- MDGL vs SNDR Comparison
MDGL vs SNDR Comparison
Compare MDGL & SNDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- SNDR
- Stock Information
- Founded
- MDGL 2011
- SNDR 1935
- Country
- MDGL United States
- SNDR United States
- Employees
- MDGL N/A
- SNDR N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- SNDR Trucking Freight/Courier Services
- Sector
- MDGL Health Care
- SNDR Industrials
- Exchange
- MDGL Nasdaq
- SNDR Nasdaq
- Market Cap
- MDGL 6.4B
- SNDR 5.2B
- IPO Year
- MDGL N/A
- SNDR 2017
- Fundamental
- Price
- MDGL $340.14
- SNDR $29.81
- Analyst Decision
- MDGL Buy
- SNDR Buy
- Analyst Count
- MDGL 14
- SNDR 14
- Target Price
- MDGL $351.67
- SNDR $29.31
- AVG Volume (30 Days)
- MDGL 392.5K
- SNDR 742.2K
- Earning Date
- MDGL 02-26-2025
- SNDR 01-30-2025
- Dividend Yield
- MDGL N/A
- SNDR 1.28%
- EPS Growth
- MDGL N/A
- SNDR N/A
- EPS
- MDGL N/A
- SNDR 0.64
- Revenue
- MDGL $76,813,000.00
- SNDR $5,323,100,000.00
- Revenue This Year
- MDGL N/A
- SNDR N/A
- Revenue Next Year
- MDGL $195.95
- SNDR $10.07
- P/E Ratio
- MDGL N/A
- SNDR $46.73
- Revenue Growth
- MDGL N/A
- SNDR N/A
- 52 Week Low
- MDGL $168.25
- SNDR $20.50
- 52 Week High
- MDGL $368.29
- SNDR $33.90
- Technical
- Relative Strength Index (RSI)
- MDGL 61.81
- SNDR 49.64
- Support Level
- MDGL $266.44
- SNDR $29.50
- Resistance Level
- MDGL $343.97
- SNDR $30.80
- Average True Range (ATR)
- MDGL 20.88
- SNDR 0.71
- MACD
- MDGL 2.00
- SNDR 0.11
- Stochastic Oscillator
- MDGL 92.59
- SNDR 57.79
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.
About SNDR Schneider National Inc.
Schneider National Inc is a provider of surface transportation and logistics solutions in North America. The Company offers truckload, intermodal, and logistics services to a diverse customer base throughout the continental United States, Canada, and Mexico. The company's segments include Truckload; Intermodal; Logistics and other. It generates maximum revenue from the Truckload segment.